---
document_datetime: 2023-09-21 17:17:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cinryze-epar-all-authorised-presentations_en.pdf
document_name: cinryze-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.699386
conversion_datetime: 2025-12-26 12:22:45.196964
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA(EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Immediate Packaging                         | Content (concentration)      | Pack size                                                                                                                 |
|-----------------|-------------------|------------|-----------------------------------------------|---------------------------|---------------------------------------------|------------------------------|---------------------------------------------------------------------------------------------------------------------------|
| EU/1/11/688/001 | Cinryze           | 500 U      | Powder and solvent for solution for injection | Intravenous use           | powder: vial (glass); solvent: vial (glass) | Powder: 500 U; Solvent: 5 ml | 2 powder vials 2 solvent vials 2 filter transfer devices 2 disposable 10ml syringes 2 venipuncture sets 2 protective mats |